Europe Patient Registry Software Market

Market Introduction

A patient registry is the database that collects uniform data about a population of disease or condition, and that aids a predefined clinical or scientific. Patient registry software contains databases that are maintained through collection of secondary data related to diagnosis, procedure, or condition of patient, for noting the number of new medical devices being used or going through a new procedure. The patient registry software plays a crucial role in post-marketing surveillance of pharmaceuticals.

Thus, a development of digital infrastructure in healthcare is expected to create a significant demand for patient registry software in the coming years, which is further anticipated to drive the patient registry software market.

Due to the second wave of COVID-19 cases, the government of many countries is working towards scaling up testing capacity. Many pharmaceutical companies in the region are actively engaged in the development of COVID-19 vaccine. Some have donated potential compound to be used for emergency use and clinical trials, including compounds formerly tested on other viral pathogens such as Ebola. Many companies are utilizing existing technologies that provide the ability to rapidly upscale production once a potential vaccine candidate is identified. Pharmaceutical companies are prioritizing research and development of COVID-19 related diagnostics, treatments, health technologies and vaccines. Moreover, companies and research centers are focusing on utilization of smart technologies to gather patient data, which will enable them to generate insights and take data-driven decisions. In March 2020, the German Society of Infectious Diseases (DGI) announced the launch of a European patient registry in order to gather and analyze clinical data of covid-19 infected patients. Moreover, the software offers significant level of anonymity, enabling patients to practice their right to privacy. Preference for adoption of such technologies offers a favorable environment for growth of Europe patient registry software market during the forecast period.

Market Overview and Dynamics

The Europe patient registry software market is expected to grow from US$ 355.4 million in 2020 to US$ 820.4 million by 2027; it is estimated to grow at a CAGR of 12.7% from 2020 to 2027. Cloud-based or web-based electronic health records (EHRs) have been used by independent physicians since the past few years. Various organizations are establishing and developing cloud-based registries for multiple medical conditions and procedures. For instance, the Orphan Disease Center collaborated with Pulse Infoframe—a medical informatics company—to build a suite of rare disease patient registries on cloud-based technologies. The emergence of similar cloud-based patient registries is expected to offer lucrative opportunities for the global patient registry software market players during the forecast period.

Key Market Segments

In terms of software, the integrated segment accounted for the largest share of the Europe patient registry software market in 2019. In terms of database, the commercial segment held a larger market share of the patient registry software market in 2019. In terms of type of registry, the disease registry segment held a larger market share of the patient registry software market in 2019. In terms of mode of delivery, the cloud-based segment held a larger market share of the patient registry software market in 2019. In terms of pricing model, the subscription segment held a larger market share of the patient registry software market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the patient registry software market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are IQVIA Inc., Medstreaming, Open Text Corporation, LUMEDX, IBM Corporation, Mckesson Corporation, and Dacima Software Inc.

Reasons to buy report

• To understand the Europe patient registry software market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe patient registry software market
• Efficiently plan M&A and partnership deals in Europe patient registry software market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe patient registry software market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

EUROPE PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION

By Software

• Standalone
• Integrated

By Database

• Public
• Commercial

By Type of Registry

• Product Registry
• Disease Registry
  • Cardiovascular Disease Registry
  • Others
• Health Service Registry

By Mode of Delivery

• On-Premises
• Cloud-Based

By Pricing Model

• Ownership
• Subscription

By Country

• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Companies Mentioned

1. IQVIA Inc.
2. Medstreaming
3. Open Text Corporation
4. LUMEDX
5. IBM Corporation
6. Mckesson Corporation
7. Dacima Software Inc

Europe Patient Registry Software Market Strategic Insights

Europe Patient Registry Software Market Segmentation Analysis

Europe Patient Registry Software Market Report Highlights

Europe Patient Registry Software Report Scope

Europe Patient Registry Software Market Country and Regional Insights